Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
... forma net operating loss of $1.3 million for the second
quarter compared to pro forma net operating ... amortizing the license fee into revenue in the second
Isis received a $375,000 ...
Net loss from continuing operations for the second
quarter of 2009 was $3.8 million compared to net ...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... ) today reported its financial results for the second
quarter ended June 30, 2009.
Net loss for ... loss of $33.4 million or $0.36 per share in the second
quarter of 2008.
Nektar made ... expenses were down 19% to $43.5 million in the second
quarter of 2009 as compared to $53.8 million in ...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
... Assuming positive results in November from our second
Phase 3 trial of BENLYSTA, we and GSK plan to ... belimumab can reduce SLE disease activity, and a second
Phase 3 trial, BLISS-76, is underway to confirm ... in systemic lupus erythematosus; results of the second
BENLYSTA Phase 3 trial are expected in November ...
Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference
... risk of dementia associated with PTSD.
study suggests lower Alzheimer's risk among ... and had the fastest rate of decline.
study in post-menopausal women found that ... participants for clinical studies is the second
greatest barrier to developing better treatments ...
Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
... Preliminary top-line results of second
Phase III study show highly significant decreases ... positive preliminary top-line results from the second
of two Phase III clinical trials of sodium ... impact on patients' quality of life."
14-week Phase III trial, conducted in the United ...
Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
... Inc. announced today the initiation of a second
Phase 2 clinical trial with a novel drug ... treatment has the potential to impact the second
phase of HCV virus inhibitory kinetics in ... postulated to have the greatest impact on HCV second
phase inhibition, leading us to evaluate CTS-1027 ...
Gene Findings Unlocking Reasons for Neuroblastoma Risk
... to a high-risk form of neuroblastoma.
genome-wide study found that a copy number ... or early childhood development.
study, spearheaded by Dr. Sharon Diskin, also of ... is among the largest in the country, ranking second
in National Institutes of Health funding. In ...
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
... progression free rate supports advancement into second
stage of Simon 2-Stage designed trial -
... met the efficacy criteria for advancement to the second
stage of enrollment. To date, 29 patients have ... the Phase II trial will now advance to the second
stage and enroll a total of approximately 25 ...
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
Jazz Pharmaceuticals has completed its second
Phase III clinical trial of JZP-6 and expects to ... mid-2009. Assuming positive results for the second
study, the company anticipates submitting a New ... including the timing of results from the second
Phase III pivotal clinical trial and the ...
DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
... anticipate patient enrollment to commence in the second
half of 2009."
About orBec (R)
Two ... the Fred Hutchinson Cancer Research Center. The second
trial was a 129-patient pivotal Phase 3 ... trial of DOR201 in radiation enteritis in the second
half of 2009. orBec(R) is also currently the ...
Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
... and evaluated and then the study is expanded to a second
larger cohort of patients if pre-specified ... the criteria for expanding enrollment to the second
cohort. Enrollment of the expanded cohort is now ... on the entire clinical study populations in the second
half of 2009."
About Phosphatidylserine ...
Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
Cervical cancer is the world's second
most commonly diagnosed women's cancer, and the second
most common cause of cancer death in women.(1)
... globally each year, cervical cancer is the second
most common cancer diagnosed among women ...
Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
... rather than the patient coming back for a second
endoscopic and/or surgical procedure.
... the ileo-cecal valve in 44 minutes.
pan-endoscopy was completed in two procedures by ... approach and the maximum depth was marked. The second
procedure was performed on the same patient at a ...
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
... Inc. today announced positive results from a second
phase 3 trial of Clonicel demonstrating that the ... when used alone, and now we have evidence from a second
study that Clonicel also has a complementary ... current study of 200 children with ADHD is the second
phase 3 trial in a year to investigate the safety ...
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
... upcoming EASL meeting. Pharmasset's unpartnered second
generation HCV nucleoside, PSI-7851, is ... expect to report the first antiviral data in the second
half of 2009. In addition, we are collecting ... Phase 2 clinical trial. PSI-7851, an unpartnered second
generation HCV nucleotide analogue recently ...
Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
... regimen that helps to prolong life."
component of the trial will examine the safety of ... been approved to improve lung hydration.
Phase III clinical trial is actively recruiting ... Argentina, Germany, Belgium and France. This second
has been designed with the assistance of ...
QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
... that it has completed enrollment in the Company's second
pivotal Phase 3 clinical trial of Ophena(TM) ... dose of either Ophena(TM) or placebo in the second
Phase 3 clinical trial. Due to the high level of ... dryness and dyspareunia.
The study is the second
pivotal Phase 3 clinical trial for Ophena(TM) , ...
Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
... study in healthy volunteers with PSI-7851, a second
generation nucleotide analog polymerase inhibitor ... for Pharmasset. PSI-7851 is a wholly owned, second
generation nucleotide analog that was discovered ... the first antiviral data with PSI-7851 in the second
half of 2009."
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
... bioabsorbable drug eluting coronary stent. This second
phase of the ABSORB clinical trial will enroll ... support. The first patient was enrolled into the second
stage of the ABSORB clinical trial at Onze Lieve ... have been eager to enroll their patients into the second
stage of the trial," said John Ormiston, M.D., ...
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
... 3 trial announced in December 2008; data from second
trial expected March 2009 -
- Phase 3 ... data were positive. We will have results of the second
Albuferon Phase 3 trial in March 2009, and the ... License Application (BLA) with the FDA in the second
quarter of 2009. HGS will receive an additional ...
Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
... ) today announced completion of enrollment in the second
two Phase III pivotal clinical trials of JZP-6 ...
"Completion of enrollment in this second
trial is a meaningful milestone
in the JZP-6 ... results were announced in November 2008. The second
Phase III study
has enrolled 575 patients at ...
Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
... Amigal to Initiate Phase 3 Global Development in second
Quarter; Continued Strong Financial Position
... Amigal for the treatment of Fabry disease in the second
quarter of 2009. Amicus also reviewed data on the ... Amicus continued discussions with the FDA in the second
half of 2008. The Agency has indicated that it ...
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
... C. We will have the results of Albuferon's second
Phase 3 trial in March. Assuming the second
trial is also successful, we expect that global ... Biologics License Application with the FDA in the second
Darapladib: GSK Phase ...
Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
... Kidney transplantation to be Quark's second
indication with clinical-stage, systemically ... kidney transplantation. DGF represents Quark's second
indication being evaluated for the systemically ... patients at high risk to develop DGF. The second
part of the study will evaluate safety and ...
Pharmasset Reports Fiscal Year End 2008 Financial Results
... 2008, Pharmasset nominated PSI-7851 as its lead, second
nucleotide candidate for HCV. ... 2009
-- Report phase 1 data with PSI-7851 in second
half of 2009
... Pharmasset also anticipates filing an IND for its second
nucleotide inhibitor for HCV, PSI-7851 ...
Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
... percent of patients in the VcD arm required a second
compared with 47 percent of patients ... and days 9 through 12 during only the first and second
cycles. Patients in
the VAD arm received ... 12 and 17 through 20 during only the
first and second
Superior Complete Response Rate ...
Brain Waves Show Sound Processing Abnormalities in Autistic Children
... Dr. Roberts said. "We see a fraction of a second
delay in autistic patients."
Autism is a ... children with autism there was a fraction of a second
delay in the brain's response while processing ... processing system is delayed a fraction of a second
in children with autism.
Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
... Phase III clinical
trial program also includes a second
randomized, double blind,
placebo-controlled ... 90% of the subjects have been enrolled in this second
trial. Jazz Pharmaceuticals anticipates ... trials for
its product candidates, including the second
Phase III clinical trial of the
sodium oxybate ...
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
four serotypes of dengue one month after the second
injection (Day 56), and
were highly protected ... all four
serotypes of dengue one month after the second
injection (Day 56), and were
partially protected ... often occurs in children infected for a second
time (with a different
serotype of dengue), and ...
Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
... dose of VYVANSE the first week and placebo
week. The second
group received placebo the first week and their
optimal dose of VYVANSE the second
The primary objective of this study was ...
Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
... trial, expected by mid-2009 - - Data from second
Phase 3 trial, BLISS-76, expected by fall 2009 -
and initial dosing in BLISS-76, the second
of two pivotal Phase 3
randomized clinical trials ... Phase 3 trial by mid-2009, and
data from our second
Phase 3 trial by fall 2009. Assuming positive ...
Cardium Reports on Second Quarter 2008 Highlights and Financial Results
... as well as
financial results for its second
quarter ended June 30, 2008.
(Logo: ... depreciation and amortization for the second
fiscal 2008 totaled $943,000. Total revenue for the second
quarter 2008 was
$627,000, compared to $229,000 ...
Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
... advanced breast cancer. The new trial is the second
Phase II study
evaluating bavituximab in advanced ... endpoint needed to
expand the trial to the second
stage. Seven of the 14 evaluable ... most
commonly diagnosed cancer in women, and is second
only to lung cancer as a
leading cause of female ...
Amicus Therapeutics Announces Second Quarter 2008 Financial Results
... today announced financial results for the second
of 2008. On a reported basis calculated ... securities totaled $145.0
quarter of 2008 was significant for Amicus. We ... President and CEO of Amicus Therapeutics.
"In the second
half of 2008, we will be focused on finalizing ...
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
... trial, and have initiated dosing of our second
AZ-004 Phase 3
clinical trial. In addition, we ... this
trial before the end of September 2008.
Phase 3 clinical trial was initiated in July 2008 ... an
end of Phase 2 meeting with the FDA during the second
quarter of 2008 and
has been granted this meeting ...
Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
... plan to initiate by the end of
this year, and the second
late-stage study of mipomersen, a ... for this indication is
anticipated during the second
half of 2010.
Genzyme and Isis plan to begin ... LDL cholesterol in high-risk
patients during the second
half of 2008. These trials will include: one ...
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
... today reported its financial results for the second
2008 and updated clinical progress of ... Significant one
time transactions during the second
quarter of 2008 included the sale of
the rights ... and investments to fund operations during the second
half of 2008. The
Company expects to end 2008 ...
Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
... ALXA ) announced today that it has initiated
Phase 3 clinical trial with AZ-004 (Staccato(R) ... our AZ-004 NDA plan with the start of
Phase 3 clinical trial this year. We look forward ... sales
and marketing of AZ-004."
Phase 3 Clinical Trial Design
BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
... - second
instance where survival increase is observed in ... for patients receiving
Tavocept. This is the second
Tavocept clinical trial where this pattern ... from the Japan
Tavocept Trial, and represent the second
time we have seen this type of a
AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine
... already begun for the clinical trial of a second
Alzheimer's vaccine by
Vienna-based ... to
offer participation in clinical testing of our second
AFFITOPE AD02. The support ... treatment, Alzheimer's is one
such disease. The second
disease that AFFiRiS has chosen to tackle ...